期刊文献+

转化生长因子β1及其在肝癌形成中的作用 被引量:5

TGF-β1 and its role in hepatocarcinogenesis
原文传递
导出
摘要 转化生长因子β1(TGF-β1)是一种多功能细胞因子,在细胞生长、分化、细胞外基质形成、凋亡、细胞迁移等方面扮演重要角色。许多研究表明肝癌细胞中TGF-β1的mRNA和蛋白质的含量比正常组织的肝细胞显著升高。TGF-β1是肿瘤抑制因子,然而在许多肿瘤中却表现为促进肿瘤的形成,如促进细胞外基质沉积、抑制凋亡、降低患者免疫力。 Transforming growth factor-β1 ( TGF-β1 ) is a multifunction growth factor that plays a role in cell proliferation, differentiation, extracellular matrix production, apoptosis and cell migration. It has also been demonstrated that the production of TGF-β1 is markedly increased at both the mRNA and protein level in HCC cell in comparison to that in the cells of normal tissues. It is known that TGF-β1 is a tumor suppression cytokine, however, it promotes progression of tumorigenesis by accelerating extracellular matrix deposition, suppressing apoptosis,lowering immunity of patients in many tumors
出处 《国际肿瘤学杂志》 CAS 2007年第4期289-292,共4页 Journal of International Oncology
基金 国家自然科学基金资助项目(30160032,30360037)
关键词 转化生长因子Β 肝细胞 细胞凋亡 新生血管化 病理性 肿瘤转移 Transforming growth factor beta Carcinoma,hepatocellular Apoptosis Neovascularization, pathologic Neoplasm metastasis
  • 相关文献

参考文献3

二级参考文献47

  • 1[1]Oka M,Iizuka N,Yamamoto K,Gondo T,Abe T,Hazama S,Akitomi Y,Koishihara Y,Ohsugi Y,Ooba Y,Ishihara T,Suzuki T.The influence of interleukin -6 on the growth of human esophageal cancer cell lines.J Interferon Cytokine Res 1996; 16:1001-1006
  • 2[2]Miki S,Iwano M,Miki Y,Yamamoto M,Tang B,Yokokawa K,Sonoda T,Hirano T,Kishimoto T.Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas.FEBS Lett 1989; 250:607-610
  • 3[3]Lee JD,Sievers TM,Skotzko M,Chandler CF,Morton DL,McBride WH,Economou JS.Interleukin-6 production by human melanoma cell lines.Lymphokine Cytokine Res 1992; 11:161-166
  • 4[4]Siegall CB,Schwab G,Nordan RP,FitzGerald DJ,Pastan Ⅰ.Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells.Cancer Res 1990; 50:7786-7788
  • 5[5]Watson JM,Sensintaffar JL,Berek JS,Martinez-Maza O.Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures.Cancer Res 1990;50:6959-6965
  • 6[6]Bataille R,Jourdan M,Zhang XG,Klein B.Serum levels of interleukin 6,a potent myeloma cell growth factor,as a reflect of disease severity in plasma cell dyscrasias.J Clin Invest 1989;84:2008-2011
  • 7[7]Tsukamoto T,Kumamoto Y,Miyao N,Masumori N,Takahashi A,Yanase M.Interleukin-6 in renal cell carcinoma.J Urol1992; 148:1778-1781; discussion 1781-1782
  • 8[8]Seguchi T,Yokokawa K,Sugao H,Nakano E,Sonoda T,Okuyama A.Interleukin-6 activity in urine and serum in patients with bladder carcinoma.J Urol1992; 148:791-794
  • 9[9]Yanagawa H,Sone S,Takahashi Y,Haku T,Yano S,Shinohara T,Ogura T.Serum levels of interleukin-6 in patients with lung cancer.Br J Cancer 1995; 71:1095-1098
  • 10[10]Berek JS,Chung C,Kaldi K,Watson JM,Knox RM,MartinezMaza O.Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer.Am J Obstet Gynecol 1991; 164:1038-1042; discussion 1042-1043

共引文献113

同被引文献72

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部